Administration of the aminoglycoside antibiotic, gentamicin, even at therapeutic doses, causes renal lysosomal phospholipidosis. We now report that protein- and lipid-bound sialic acid levels are increased significantly in a time-dependent fashion in the renal cortex of rats injected with gentamicin (10 mg/kg body wt. per day) for 4-10 days and a significant relationship could be observed between these two parameters. This elevation was not due to tissue regeneration, since it was not observed in cisplatin-treated animals
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
A substantial amount of data is available to suggest that lysosomal sequestration of amino-glycoside...
Coadministration of polyaspartic acid protects against functional and pathological signs of gentamic...
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
The effect of phospholipids on gentamicin-induced nephrotoxicity was studied in Sprague-Dawley rats....
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. The recov...
Aminoglycoside antibiotics, such as gentamicin, cause an early lysosomal phospholipidosis in the ren...
Increased nephrotoxicity of gentamicin in pyelonephritic rats. Multiple factors may increase the nep...
Coadministration of poly-L-aspartic acid (poly-L-Asp) protects rats against all measured signs of am...
Coadministration of polyaspartic acid protects rats against aminoglycoside-induced nephrotoxicity, w...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
A substantial amount of data is available to suggest that lysosomal sequestration of amino-glycoside...
Coadministration of polyaspartic acid protects against functional and pathological signs of gentamic...
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
The effect of phospholipids on gentamicin-induced nephrotoxicity was studied in Sprague-Dawley rats....
Les aminoglycosides sont des antibiotiques néphrotoxiques. La première altération qu’ils induisent a...
Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. The recov...
Aminoglycoside antibiotics, such as gentamicin, cause an early lysosomal phospholipidosis in the ren...
Increased nephrotoxicity of gentamicin in pyelonephritic rats. Multiple factors may increase the nep...
Coadministration of poly-L-aspartic acid (poly-L-Asp) protects rats against all measured signs of am...
Coadministration of polyaspartic acid protects rats against aminoglycoside-induced nephrotoxicity, w...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
Poly-L-aspartic acid (poly-L-Asp) protects rats against gentamicin (GM)-induced nephrotoxicity (func...
A substantial amount of data is available to suggest that lysosomal sequestration of amino-glycoside...